Failure to Obtain Psychotropic Medication Consent for Cognitively Impaired Residents
Penalty
Summary
The facility failed to ensure that three residents with cognitive impairment were fully informed and able to make treatment decisions regarding their prescribed psychotropic medications. Record review showed that all three residents had significant cognitive deficits, as indicated by low BIMS scores, and were dependent on staff for activities of daily living and hygiene. Each resident had been prescribed psychotropic medications, including quetiapine fumarate and lorazepam, for conditions such as Alzheimer's disease, dementia, depression, anxiety, and related symptoms. Despite these prescriptions, there were no signed psychotropic medication consent forms in the medical records of any of the three residents. Additionally, the facility did not have a policy in place regarding obtaining consent for psychotropic medications from residents or their representatives. The DON confirmed during interviews that the facility lacked both the required consent forms and a related policy.